Cytogen (CYTO) Hires ThinkEquity Partners To Evaluate Strategic Alternatives
Cytogen Corporation (NASDAQ: CYTO) engaged ThinkEquity Partners LLC, to assist the Company in identifying and evaluating strategic alternatives intended to enhance the future growth potential of the Company’s pipeline and maximize shareholder value.
Create E-mail AlertRelated Categories
Corporate NewsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
